Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick...

Area of Science:

• Biochemistry
• Molecular Biology
• Nutritional Science

Background:

• Plant stanol esters are known for their cholesterol-lowering properties.
• The precise molecular mechanisms underlying their efficacy, particularly involving intestinal sterol transporters, require further elucidation.

Purpose of the Study:

• To investigate the impact of plant stanol esters on cholesterol metabolism in hamsters.
• To examine the relationship between stanol ester consumption and the mRNA expression of key intestinal sterol transporters, including ABCA1, ABCG1, ABCG5, ABCG8, and NPC1L1.

Main Methods:

• Hamsters were fed diets containing plant stanol esters, cholesterol, or a combination of cholestyramine/lovastatin.
• mRNA levels of specific sterol transporters (ABCA1, ABCG1, ABCG5, ABCG8, NPC1L1) were quantified in the duodenum, jejunum, and ileum.
• Plasma cholesterol and plant sterol levels were measured.

Main Results:

• Plant stanol esters reduced plasma cholesterol by 36%, while cholestyramine/lovastatin reduced it by 94%.
• Cholesterol feeding increased plasma cholesterol, and stanols accumulated in enterocytes.
• Stanol ester and cholestyramine/lovastatin treatments decreased ABCG5 and ABCG8 mRNA levels.
• Cholesterol feeding increased ABCA1 and ABCG1 expression, but NPC1L1 mRNA levels were not significantly altered by any diet.
• Distinct cellular localization patterns were observed for ABCA1 compared to other transporters.

Conclusions:

• The cholesterol-lowering effect of plant stanol esters appears unrelated to alterations in the mRNA levels of intestinal ABC sterol transporters or NPC1L1.
• Intestinal cholesterol flux influences ABC transporter expression, but not NPC1L1.
• The differential localization of ABCA1 suggests a unique functional role compared to ABCG1, ABCG5, ABCG8, and NPC1L1.